Now Available: Final Rule for FDAAA 801 and NIH Policy on Clinical Trial Reporting

Effect of Somatropin on Left Ventricular Mass in Growth Hormone Deficient Adult Patients

This study has been completed.
Sponsor:
Information provided by:
Novo Nordisk A/S
ClinicalTrials.gov Identifier:
NCT01562834
First received: March 22, 2012
Last updated: June 28, 2012
Last verified: June 2012
No Study Results Posted on ClinicalTrials.gov for this Study
  Study Status: This study has been completed.
  Study Completion Date: December 2002
  Primary Completion Date: December 2002 (Final data collection date for primary outcome measure)